Concepts (326)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 47 | 2026 | 319 | 8.370 |
Why?
|
| Isocyanates | 20 | 2026 | 47 | 4.760 |
Why?
|
| Fluorocarbons | 7 | 2026 | 52 | 3.500 |
Why?
|
| Air Pollutants, Occupational | 15 | 2026 | 75 | 2.940 |
Why?
|
| Nanoparticles | 23 | 2025 | 544 | 2.910 |
Why?
|
| Environmental Pollutants | 4 | 2025 | 97 | 2.270 |
Why?
|
| Inhalation Exposure | 14 | 2020 | 54 | 2.270 |
Why?
|
| Paint | 10 | 2026 | 23 | 2.240 |
Why?
|
| Oxidative Stress | 10 | 2026 | 319 | 2.220 |
Why?
|
| Polyurethanes | 9 | 2022 | 29 | 2.050 |
Why?
|
| Titanium | 8 | 2025 | 59 | 1.770 |
Why?
|
| Air Pollutants | 11 | 2023 | 98 | 1.750 |
Why?
|
| Environmental Monitoring | 22 | 2026 | 154 | 1.750 |
Why?
|
| Nanostructures | 7 | 2018 | 187 | 1.670 |
Why?
|
| Epoxy Resins | 3 | 2024 | 4 | 1.440 |
Why?
|
| Environmental Exposure | 3 | 2025 | 226 | 1.380 |
Why?
|
| Epoxy Compounds | 3 | 2026 | 11 | 1.350 |
Why?
|
| Tandem Mass Spectrometry | 6 | 2026 | 137 | 1.180 |
Why?
|
| Printing | 8 | 2025 | 21 | 1.120 |
Why?
|
| Capsid | 2 | 2026 | 104 | 1.080 |
Why?
|
| Capsid Proteins | 2 | 2026 | 107 | 1.080 |
Why?
|
| Transduction, Genetic | 2 | 2026 | 243 | 1.030 |
Why?
|
| Construction Industry | 3 | 2024 | 20 | 0.980 |
Why?
|
| Skin Absorption | 7 | 2016 | 16 | 0.950 |
Why?
|
| Skin | 7 | 2020 | 419 | 0.940 |
Why?
|
| Air Pollution, Indoor | 7 | 2017 | 38 | 0.920 |
Why?
|
| Biomarkers | 10 | 2026 | 1476 | 0.900 |
Why?
|
| Copying Processes | 5 | 2024 | 10 | 0.890 |
Why?
|
| Avena | 1 | 2024 | 7 | 0.880 |
Why?
|
| beta-Glucans | 1 | 2024 | 51 | 0.850 |
Why?
|
| Dietary Fiber | 1 | 2024 | 79 | 0.830 |
Why?
|
| Nanotubes, Carbon | 6 | 2016 | 19 | 0.820 |
Why?
|
| Respiratory Tract Diseases | 2 | 2021 | 39 | 0.760 |
Why?
|
| Automobiles | 8 | 2008 | 66 | 0.760 |
Why?
|
| Toxicity Tests | 3 | 2018 | 19 | 0.750 |
Why?
|
| Genetic Vectors | 2 | 2026 | 917 | 0.740 |
Why?
|
| Gastrointestinal Tract | 3 | 2019 | 189 | 0.740 |
Why?
|
| Dependovirus | 2 | 2026 | 750 | 0.720 |
Why?
|
| Inflammation | 4 | 2025 | 1186 | 0.710 |
Why?
|
| Occupational Diseases | 5 | 2024 | 265 | 0.690 |
Why?
|
| Liver | 4 | 2026 | 868 | 0.650 |
Why?
|
| Humans | 71 | 2026 | 64934 | 0.650 |
Why?
|
| Manufacturing Industry | 2 | 2017 | 3 | 0.640 |
Why?
|
| Benzhydryl Compounds | 7 | 2024 | 61 | 0.620 |
Why?
|
| Workplace | 7 | 2021 | 179 | 0.600 |
Why?
|
| Food Additives | 2 | 2022 | 27 | 0.600 |
Why?
|
| Hydrogen Peroxide | 1 | 2019 | 83 | 0.590 |
Why?
|
| Hazardous Substances | 4 | 2024 | 16 | 0.580 |
Why?
|
| Dipeptides | 1 | 2019 | 68 | 0.570 |
Why?
|
| Gastric Juice | 1 | 2018 | 9 | 0.570 |
Why?
|
| Flame Retardants | 1 | 2018 | 6 | 0.550 |
Why?
|
| Organophosphates | 1 | 2018 | 14 | 0.550 |
Why?
|
| Particle Size | 14 | 2020 | 428 | 0.540 |
Why?
|
| Water Pollutants, Chemical | 4 | 2026 | 43 | 0.540 |
Why?
|
| Particulate Matter | 6 | 2019 | 70 | 0.530 |
Why?
|
| Lipid Peroxidation | 1 | 2016 | 67 | 0.500 |
Why?
|
| Metal Nanoparticles | 2 | 2017 | 190 | 0.480 |
Why?
|
| Pilot Projects | 3 | 2025 | 1013 | 0.450 |
Why?
|
| Animals | 21 | 2026 | 21286 | 0.440 |
Why?
|
| Engineering | 1 | 2014 | 10 | 0.430 |
Why?
|
| Dust | 7 | 2024 | 42 | 0.430 |
Why?
|
| Construction Materials | 3 | 2024 | 16 | 0.420 |
Why?
|
| Materials Testing | 4 | 2019 | 88 | 0.410 |
Why?
|
| Singapore | 3 | 2023 | 10 | 0.410 |
Why?
|
| Mice | 10 | 2026 | 11085 | 0.400 |
Why?
|
| Reactive Oxygen Species | 4 | 2019 | 237 | 0.400 |
Why?
|
| Nanotechnology | 1 | 2014 | 139 | 0.390 |
Why?
|
| Aerosols | 2 | 2012 | 46 | 0.380 |
Why?
|
| Environmental Health | 1 | 2012 | 14 | 0.370 |
Why?
|
| Chromatography, Liquid | 3 | 2026 | 117 | 0.370 |
Why?
|
| Metals | 4 | 2020 | 65 | 0.350 |
Why?
|
| Protective Clothing | 3 | 2024 | 29 | 0.340 |
Why?
|
| Male | 16 | 2026 | 30942 | 0.340 |
Why?
|
| Printing, Three-Dimensional | 3 | 2023 | 42 | 0.330 |
Why?
|
| Cyanates | 2 | 2007 | 4 | 0.320 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 4 | 2014 | 39 | 0.320 |
Why?
|
| DNA Damage | 4 | 2016 | 297 | 0.310 |
Why?
|
| Occupational Health | 5 | 2025 | 193 | 0.310 |
Why?
|
| Dermatitis, Occupational | 2 | 2016 | 4 | 0.310 |
Why?
|
| Quartz | 4 | 2011 | 8 | 0.300 |
Why?
|
| Adult | 12 | 2026 | 17306 | 0.290 |
Why?
|
| Food Safety | 2 | 2019 | 10 | 0.290 |
Why?
|
| New England | 2 | 2020 | 270 | 0.290 |
Why?
|
| Personal Protective Equipment | 2 | 2020 | 27 | 0.290 |
Why?
|
| Cell Line | 7 | 2025 | 2020 | 0.290 |
Why?
|
| Triazines | 2 | 2006 | 22 | 0.290 |
Why?
|
| Silicon Dioxide | 2 | 2019 | 63 | 0.280 |
Why?
|
| Body Burden | 2 | 2026 | 12 | 0.280 |
Why?
|
| Deoxyguanosine | 2 | 2026 | 19 | 0.270 |
Why?
|
| Cytokines | 5 | 2021 | 951 | 0.260 |
Why?
|
| Asthma | 3 | 2024 | 483 | 0.250 |
Why?
|
| Agricultural Irrigation | 1 | 2026 | 2 | 0.250 |
Why?
|
| Tissue Fixation | 1 | 2026 | 20 | 0.240 |
Why?
|
| Paraffin Embedding | 1 | 2026 | 18 | 0.240 |
Why?
|
| Formaldehyde | 1 | 2026 | 33 | 0.240 |
Why?
|
| Dermatitis, Contact | 2 | 2024 | 12 | 0.240 |
Why?
|
| Occupations | 1 | 2026 | 52 | 0.240 |
Why?
|
| Graphite | 2 | 2016 | 15 | 0.240 |
Why?
|
| Dermatitis | 1 | 2006 | 27 | 0.240 |
Why?
|
| Spectrum Analysis, Raman | 1 | 2025 | 24 | 0.230 |
Why?
|
| Nanofibers | 2 | 2016 | 20 | 0.230 |
Why?
|
| Middle Aged | 7 | 2026 | 18203 | 0.230 |
Why?
|
| Air Microbiology | 1 | 2025 | 11 | 0.230 |
Why?
|
| Alkanesulfonic Acids | 1 | 2025 | 10 | 0.230 |
Why?
|
| Oxides | 4 | 2019 | 36 | 0.230 |
Why?
|
| Decontamination | 1 | 2005 | 12 | 0.230 |
Why?
|
| Gloves, Protective | 4 | 2019 | 7 | 0.230 |
Why?
|
| Detergents | 1 | 2005 | 34 | 0.230 |
Why?
|
| Trichloroethylene | 1 | 2025 | 1 | 0.220 |
Why?
|
| Polymers | 2 | 2006 | 332 | 0.220 |
Why?
|
| Inulin | 1 | 2024 | 3 | 0.220 |
Why?
|
| Azides | 1 | 2025 | 22 | 0.220 |
Why?
|
| Binge Drinking | 1 | 2025 | 38 | 0.220 |
Why?
|
| Canada | 1 | 2025 | 153 | 0.220 |
Why?
|
| Dysbiosis | 1 | 2025 | 74 | 0.220 |
Why?
|
| Cell Survival | 6 | 2019 | 587 | 0.210 |
Why?
|
| Leukocyte L1 Antigen Complex | 1 | 2024 | 5 | 0.210 |
Why?
|
| Macrophages | 5 | 2019 | 1035 | 0.210 |
Why?
|
| Surface Properties | 4 | 2019 | 283 | 0.210 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2025 | 92 | 0.210 |
Why?
|
| Lactoferrin | 1 | 2024 | 37 | 0.200 |
Why?
|
| Risk Assessment | 6 | 2019 | 2093 | 0.200 |
Why?
|
| Female | 10 | 2026 | 33915 | 0.200 |
Why?
|
| Industry | 4 | 2015 | 59 | 0.200 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2023 | 19 | 0.190 |
Why?
|
| Lung | 4 | 2016 | 962 | 0.190 |
Why?
|
| Tyrosine | 1 | 2023 | 93 | 0.190 |
Why?
|
| Zinc | 2 | 2021 | 95 | 0.190 |
Why?
|
| Molecular Structure | 2 | 2019 | 316 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2024 | 235 | 0.180 |
Why?
|
| Cocaine | 1 | 2023 | 101 | 0.180 |
Why?
|
| Ethanol | 1 | 2025 | 329 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 3 | 2025 | 3468 | 0.180 |
Why?
|
| Bacterial Translocation | 1 | 2021 | 10 | 0.180 |
Why?
|
| Self Report | 1 | 2024 | 391 | 0.180 |
Why?
|
| Ferric Compounds | 2 | 2018 | 42 | 0.170 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2025 | 261 | 0.170 |
Why?
|
| Virulence Factors | 1 | 2021 | 85 | 0.170 |
Why?
|
| Pseudomonas Infections | 1 | 2021 | 73 | 0.170 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2021 | 132 | 0.160 |
Why?
|
| Biofilms | 1 | 2021 | 85 | 0.160 |
Why?
|
| Silanes | 1 | 2019 | 3 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 6 | 2017 | 138 | 0.150 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 249 | 0.150 |
Why?
|
| Endothelial Cells | 1 | 2021 | 207 | 0.150 |
Why?
|
| Carbon Dioxide | 2 | 2017 | 81 | 0.150 |
Why?
|
| Recycling | 2 | 2016 | 4 | 0.150 |
Why?
|
| Glutathione | 1 | 2019 | 55 | 0.150 |
Why?
|
| Motor Vehicles | 2 | 2012 | 32 | 0.140 |
Why?
|
| Zinc Oxide | 1 | 2018 | 6 | 0.140 |
Why?
|
| Diet | 1 | 2022 | 533 | 0.140 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 325 | 0.140 |
Why?
|
| Elephantiasis | 1 | 2017 | 1 | 0.130 |
Why?
|
| Biological Availability | 1 | 2018 | 209 | 0.130 |
Why?
|
| Hemolysis | 1 | 2017 | 41 | 0.130 |
Why?
|
| Soil | 1 | 2017 | 27 | 0.130 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2016 | 7 | 0.130 |
Why?
|
| Malondialdehyde | 1 | 2016 | 15 | 0.130 |
Why?
|
| Breath Tests | 1 | 2016 | 14 | 0.130 |
Why?
|
| Chemical Industry | 1 | 2016 | 8 | 0.130 |
Why?
|
| Dinoprost | 1 | 2016 | 19 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2019 | 856 | 0.130 |
Why?
|
| Carbon Monoxide | 1 | 2017 | 63 | 0.120 |
Why?
|
| Electronic Nicotine Delivery Systems | 1 | 2017 | 78 | 0.120 |
Why?
|
| Volatile Organic Compounds | 2 | 2014 | 22 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2013 | 33 | 0.120 |
Why?
|
| Polypropylenes | 1 | 2015 | 7 | 0.120 |
Why?
|
| Temperature | 1 | 2017 | 314 | 0.120 |
Why?
|
| Toxicology | 1 | 2015 | 22 | 0.110 |
Why?
|
| Cytotoxins | 1 | 2015 | 11 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 750 | 0.110 |
Why?
|
| United States | 5 | 2026 | 8082 | 0.110 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2016 | 223 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 225 | 0.110 |
Why?
|
| Chemokines | 1 | 2015 | 92 | 0.110 |
Why?
|
| Nanopores | 1 | 2014 | 14 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 327 | 0.110 |
Why?
|
| Young Adult | 5 | 2026 | 4793 | 0.110 |
Why?
|
| Hypersensitivity | 2 | 2024 | 73 | 0.100 |
Why?
|
| Serum | 2 | 2011 | 27 | 0.100 |
Why?
|
| Antioxidants | 2 | 2017 | 249 | 0.100 |
Why?
|
| Ink | 1 | 2013 | 11 | 0.100 |
Why?
|
| Apoptosis | 3 | 2013 | 1100 | 0.100 |
Why?
|
| Cerebral Cortex | 1 | 2015 | 267 | 0.100 |
Why?
|
| DNA Methylation | 1 | 2015 | 302 | 0.100 |
Why?
|
| Synapses | 1 | 2015 | 193 | 0.100 |
Why?
|
| Permeability | 2 | 2025 | 50 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2015 | 417 | 0.090 |
Why?
|
| Amyloid beta-Peptides | 1 | 2015 | 321 | 0.090 |
Why?
|
| Welding | 2 | 2010 | 4 | 0.090 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2012 | 42 | 0.090 |
Why?
|
| Models, Biological | 2 | 2015 | 1192 | 0.090 |
Why?
|
| Asthma, Occupational | 1 | 2012 | 2 | 0.090 |
Why?
|
| Aged | 2 | 2026 | 14917 | 0.090 |
Why?
|
| Noise, Occupational | 1 | 2011 | 13 | 0.090 |
Why?
|
| Nitriles | 2 | 2024 | 82 | 0.090 |
Why?
|
| Aluminum | 1 | 2010 | 13 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 253 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1564 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2011 | 162 | 0.080 |
Why?
|
| Biosensing Techniques | 1 | 2011 | 125 | 0.070 |
Why?
|
| Neurons | 1 | 2015 | 933 | 0.070 |
Why?
|
| Epithelial Cells | 3 | 2017 | 410 | 0.070 |
Why?
|
| Biological Assay | 1 | 2008 | 56 | 0.070 |
Why?
|
| Albania | 1 | 2026 | 1 | 0.060 |
Why?
|
| Groundwater | 1 | 2026 | 5 | 0.060 |
Why?
|
| Respiratory Protective Devices | 1 | 2006 | 12 | 0.060 |
Why?
|
| Guinea Pigs | 1 | 2006 | 86 | 0.060 |
Why?
|
| Electrophoresis, Capillary | 1 | 2026 | 8 | 0.060 |
Why?
|
| Isoelectric Focusing | 1 | 2026 | 13 | 0.060 |
Why?
|
| Porphyromonas | 1 | 2025 | 1 | 0.060 |
Why?
|
| Chryseobacterium | 1 | 2025 | 1 | 0.060 |
Why?
|
| Cell Culture Techniques | 2 | 2019 | 195 | 0.060 |
Why?
|
| Ethanolamine | 1 | 2005 | 2 | 0.060 |
Why?
|
| Propylene Glycols | 1 | 2005 | 9 | 0.060 |
Why?
|
| Nutrition Surveys | 1 | 2026 | 149 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2025 | 105 | 0.060 |
Why?
|
| Candida | 1 | 2025 | 37 | 0.060 |
Why?
|
| Tetrachloroethylene | 1 | 2025 | 1 | 0.060 |
Why?
|
| Feces | 1 | 2025 | 118 | 0.060 |
Why?
|
| Acetylene | 1 | 2025 | 3 | 0.060 |
Why?
|
| Adolescent | 2 | 2026 | 6292 | 0.060 |
Why?
|
| Maximum Allowable Concentration | 1 | 2004 | 3 | 0.060 |
Why?
|
| Carcinogens | 1 | 2024 | 33 | 0.050 |
Why?
|
| Boston | 2 | 2002 | 257 | 0.050 |
Why?
|
| Bronchoalveolar Lavage Fluid | 2 | 2016 | 91 | 0.050 |
Why?
|
| Consumer Product Safety | 2 | 2014 | 12 | 0.050 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2024 | 26 | 0.050 |
Why?
|
| Chemical Phenomena | 2 | 2014 | 96 | 0.050 |
Why?
|
| Latex | 1 | 2024 | 5 | 0.050 |
Why?
|
| Kinetics | 1 | 2006 | 759 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2026 | 268 | 0.050 |
Why?
|
| Neoplasms | 2 | 2024 | 1364 | 0.050 |
Why?
|
| Comet Assay | 2 | 2013 | 11 | 0.050 |
Why?
|
| Fatigue | 1 | 2024 | 113 | 0.050 |
Why?
|
| 3,4-Methylenedioxyamphetamine | 1 | 2023 | 2 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 463 | 0.050 |
Why?
|
| Hydrocodone | 1 | 2023 | 6 | 0.050 |
Why?
|
| Amphetamine | 1 | 2023 | 12 | 0.050 |
Why?
|
| Carbon | 2 | 2015 | 52 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 39 | 0.050 |
Why?
|
| Microbiota | 1 | 2025 | 168 | 0.050 |
Why?
|
| Vehicle Emissions | 1 | 2002 | 23 | 0.050 |
Why?
|
| Fentanyl | 1 | 2023 | 66 | 0.050 |
Why?
|
| Methadone | 1 | 2023 | 140 | 0.040 |
Why?
|
| Caco-2 Cells | 1 | 2021 | 67 | 0.040 |
Why?
|
| Rats | 2 | 2016 | 1989 | 0.040 |
Why?
|
| Logistic Models | 1 | 2024 | 1268 | 0.040 |
Why?
|
| Rural Population | 1 | 2023 | 223 | 0.040 |
Why?
|
| Body Weight | 1 | 2022 | 374 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2187 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 1557 | 0.040 |
Why?
|
| RAW 264.7 Cells | 1 | 2019 | 50 | 0.040 |
Why?
|
| Time Factors | 1 | 2007 | 3753 | 0.040 |
Why?
|
| Textiles | 1 | 2019 | 10 | 0.040 |
Why?
|
| Holistic Health | 1 | 2019 | 12 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2026 | 837 | 0.030 |
Why?
|
| Pandemics | 1 | 2023 | 672 | 0.030 |
Why?
|
| Perception | 1 | 2019 | 181 | 0.030 |
Why?
|
| Catalase | 1 | 2017 | 21 | 0.030 |
Why?
|
| Chromans | 1 | 2017 | 16 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2025 | 2281 | 0.030 |
Why?
|
| Chromium | 1 | 2017 | 5 | 0.030 |
Why?
|
| Ethiopia | 1 | 2017 | 8 | 0.030 |
Why?
|
| Barium | 1 | 2017 | 8 | 0.030 |
Why?
|
| Manganese Compounds | 1 | 2017 | 8 | 0.030 |
Why?
|
| Calcium Compounds | 1 | 2017 | 5 | 0.030 |
Why?
|
| Minerals | 1 | 2017 | 20 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2017 | 64 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2019 | 505 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 861 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 2701 | 0.030 |
Why?
|
| Polycarboxylate Cement | 1 | 2016 | 4 | 0.030 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2016 | 9 | 0.030 |
Why?
|
| Suspensions | 1 | 2015 | 9 | 0.030 |
Why?
|
| Research | 1 | 2017 | 194 | 0.030 |
Why?
|
| Organ Size | 1 | 2016 | 173 | 0.030 |
Why?
|
| Computer Systems | 1 | 2015 | 13 | 0.030 |
Why?
|
| Eating | 1 | 2016 | 137 | 0.030 |
Why?
|
| Paper | 1 | 2015 | 13 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 2015 | 95 | 0.030 |
Why?
|
| Connecticut | 2 | 2006 | 90 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 497 | 0.030 |
Why?
|
| Powders | 1 | 2014 | 21 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2014 | 111 | 0.030 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2014 | 2 | 0.030 |
Why?
|
| Research Design | 2 | 2010 | 585 | 0.030 |
Why?
|
| Action Potentials | 1 | 2015 | 113 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 622 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2015 | 204 | 0.030 |
Why?
|
| Ozone | 1 | 2014 | 20 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2015 | 158 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 1691 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2014 | 144 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2015 | 602 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2013 | 101 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 51 | 0.020 |
Why?
|
| Albumins | 1 | 2013 | 43 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 1039 | 0.020 |
Why?
|
| Solubility | 1 | 2013 | 192 | 0.020 |
Why?
|
| Nasal Lavage Fluid | 1 | 2012 | 7 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 662 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2013 | 869 | 0.020 |
Why?
|
| Zymosan | 1 | 2011 | 24 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 2011 | 52 | 0.020 |
Why?
|
| Dogs | 1 | 2012 | 315 | 0.020 |
Why?
|
| Polystyrenes | 1 | 2011 | 35 | 0.020 |
Why?
|
| Friction | 1 | 2010 | 4 | 0.020 |
Why?
|
| Alloys | 1 | 2010 | 30 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2011 | 257 | 0.020 |
Why?
|
| Iron | 1 | 2010 | 150 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2010 | 195 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 295 | 0.020 |
Why?
|
| Mexico | 1 | 2008 | 38 | 0.020 |
Why?
|
| Developing Countries | 1 | 2008 | 87 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2371 | 0.020 |
Why?
|
| Colorimetry | 1 | 2007 | 26 | 0.020 |
Why?
|
| Safety Management | 1 | 2008 | 136 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2015 | 3141 | 0.010 |
Why?
|
| Epidemiologic Studies | 1 | 2004 | 34 | 0.010 |
Why?
|
| Data Collection | 1 | 2004 | 382 | 0.010 |
Why?
|
| Facility Design and Construction | 1 | 2002 | 12 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2002 | 61 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 5406 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2008 | 2759 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 1161 | 0.010 |
Why?
|